Glasdegib

Grey

Brand Name(s):Daurismo

Indication:Treatment of newly diagnosed de novo or secondary acute myeloid leukaemia in adult patients

Rationale:2

Considered:Nov-20

Review Date:Nov-25

Comments:
Glasdegib in an inhibitor of the Hedgehog signal transduction pathway and is licensed, in combination with low-dose cytarabine, for treatment of newly diagnosed de novo or secondary acute myeloid leukaemia in adult patients who are not candidates for standard induction chemotherapy.